Ketamine Active Not Recruiting Phase 2 Trials for Treatment Resistant Depression (TRD) Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02935595Low Dose Intravenous Ketamine in Treatment Resistant Depression Patients